SCARCITY PROFILE — SCIENTIFIC LEADERSHIP

Olimpia Baranowska

CEO · SCIENTIFIC DIRECTOR · ARCHITECT OF ZERO-CONFLICT CDMO

M.Sc. Eng. in Technical Physics and Applied Mathematics (Double Specialization: Abstract Quantum Physics & Organic Microelectronics) and Ph.D. Candidate in Medical Sciences (Specialization: Phlebology), recognized in Rome for scientific excellence. Built a 17-year operating record with zero client QA complaints while engineering a category-of-one CDMO model for defensible IP mandates.

INITIATE R&D DUE DILIGENCE DATA ROOM / LEGAL HUB →

LEADERSHIP ACCESS PROTOCOL

Not a public founder inbox. A filtered scientific mandate pipeline.

PE, enterprise, and medical operators receive direct leadership access only after gate verification. The paid due diligence step protects operating bandwidth for high-stakes mandates where IP control and execution certainty matter.

AUTO-DECLINED INTAKE

GENERAL NETWORKING REQUESTS WITHOUT EXECUTION MANDATE
PRICE-FIRST OUTREACH WITHOUT CLINICAL OR IP THESIS
PRIVATE-LABEL OR LOW-MOQ INQUIRIES SEEKING OPEN INTAKE
FREE CONSULTATION EXPECTATIONS DISGUISED AS DUE DILIGENCE

ADMISSION REQUIREMENTS

BOARD-SPONSORED PROGRAM WITH BUDGET AUTHORITY

DEFENSIBLE SCIENTIFIC OR M&A-READY IP OBJECTIVE

READINESS FOR REGULATORY, QA, AND SCALE-UP GOVERNANCE

COMMITMENT TO START WITH PAID DUE DILIGENCE

CREDENTIAL MATRIX

Physics precision fused with medical rigor.

MSc ENGINEERING

APPLIED PHYSICS AND APPLIED MATHEMATICS — GDAŃSK UNIVERSITY OF TECHNOLOGY | DOUBLE SPECIALIZATION: ABSTRACT QUANTUM PHYSICS & ORGANIC MICROELECTRONICS

PHD TRACK

MEDICAL SCIENCES — DOCTORAL STUDIES | SPECIALIZATION: PHLEBOLOGY (BIOPHYSICS · PHARMACOGENETICS · CLINICAL EFFICACY)

STRATEGIC INNOVATIONS

Built as enterprise moat, not marketing story.

ZERO-CONFLICT POLICY

NO CONSUMER BRANDS. NO INTERNAL INCENTIVE TO CLONE CLIENT FORMULAS.

AI TOXICOLOGICAL SCREENING

PROPRIETARY INTERACTION MAPPING BEFORE BATCH EXECUTION.

CAMBRIDGE TECH TRANSFER

INDUSTRIAL SCALE-UP OF PRECISION MICELLAR DELIVERY SYSTEMS.

EXTERNAL VALIDATION

Recognition from institutions, not vanity rankings.

International Leader in Scientific Excellence

International Businesswoman Awards, Rome

Awarded for scientific leadership and the Zero Conflict manufacturing model.

Best in Business Award

NCBiR Patronage (National R&D Centre)

Recognition for ethical business practices and innovation in nutraceutical manufacturing.

Business Growth Award — Chemical Industry

European Business Institute

Top dynamic growth in the chemical industry sector.

5,000 Most Dynamic Companies in Poland

European Business Institute

National ranking of fastest-growing enterprises.

Business Growth Award — Chemical Industry (2021)

European Business Institute

Consecutive year of recognition for dynamic growth (1966% dynamics).

Business Growth Award — Regional

European Business Institute

Regional leader in business growth.

Effective Company — Chemical Industry

European Business Institute

Recognition for operational efficiency and multi-year financial stability.

RESEARCH DOSSIER

Selected publications and industry papers.

Collagen — 20 Years of Scientific and Business Knowledge (Part 1): Structure, Composition and Fundamental Functions

Biotechnologia.pl

Collagen in Practice — Sources and Applications

Biotechnologia.pl

Innovations in Collagen — Modern Forms and the Future of Industry

Biotechnologia.pl

Pharmacogenetics — The Future of Personalized Medicine

Pharmaceutical Industry World

Application of Supplementation in Nervous System Protection

Pharmaceutical Industry World

Hyperbaric Oxygen Therapy in Rehabilitation

Practical Physiotherapy

Collagen Hydrolysates — Comparative Market Analysis

Cosmetic Industry World

Not All Collagen Is Equal — Market Comparison

Cosmetic Industry World

LEADERSHIP ACCESS

If your mandate is serious, initiate due diligence.

Direct CEO/scientific leadership access is reserved for enterprise operators, PE-backed teams, and medical programs with execution authority and budget commitment.

INITIATE R&D DUE DILIGENCE DATA ROOM / LEGAL HUB →

Frequently Asked Questions

Who is Olimpia Baranowska and what is her role at Olympia Biosciences™?

Olimpia Baranowska (M.Sc. Eng. in Technical Physics and Applied Mathematics — Double Specialization: Abstract Quantum Physics & Organic Microelectronics; Ph.D. Candidate in Medical Sciences — Specialization: Phlebology) is the Co-Founder, CEO, and Lead Scientific Director of Olympia Biosciences™ Ltd. She personally oversees every enterprise-level formulation project. She is the architect of Europe's Zero-Conflict CDMO model, the co-developer of Vegicoll® (world's first plant-based collagen analog), and the creator of the proprietary AI toxicology verification system featured in Forbes. In 2024, she received the International Leader in Scientific Excellence award in Rome under the patronage of NCBiR.

What is the Zero Conflict of Interest model and why does it matter for supplement brands?

The Zero Conflict of Interest model is a structural corporate architecture — not a policy — ensuring Olympia Biosciences™ has never and will never develop, manufacture, or market supplement products under its own consumer brand. This eliminates the central risk of contract manufacturing: your manufacturer studying your formula and margins to launch a competing product. It is enforced by ISO 27001:2023 information security certification, multi-layer NDA agreements, and 17 years of verifiable business history without a single consumer brand launch.

What scientific publications has Olimpia Baranowska authored?

Olimpia Baranowska has authored scientific and industry publications on collagen science (Biotechnologia.pl — 3 papers), pharmacogenetics and personalized medicine (Pharmaceutical Industry World), nervous system supplementation, hyperbaric oxygen therapy (Practical Physiotherapy), and collagen market analysis. Her research spans nutraceutical chemistry, biophysics, and clinical applications.

What international awards has Olimpia Baranowska and Olympia Biosciences™ received?

Recognition includes: International Leader in Scientific Excellence (International Businesswoman Awards, Rome), Best in Business Award under NCBiR Patronage (National R&D Centre, Poland), three consecutive Business Growth Awards in the Chemical Industry (European Business Institute), regional growth leader, recognition among the 5,000 Most Dynamic Companies in Poland, and Effective Company in the Chemical Industry.

RELATED INTELLIGENCE

Science-First Manifesto — Founder Doctrine Olimpia Baranowska's evidence-based supplementation philosophy in full EXPLORE › Physician Supplement Brand CDMO Services Clinical manufacturing under Olimpia's scientific directorship EXPLORE › 10 CDMO Technology Advantages Evidence of our manufacturing superiority across IP, scale-up, and safety EXPLORE › Schedule a Confidential Consultation Direct access to the scientific board — Paid Discovery process EXPLORE ›